SNX3-IN-1 is a sorting nexin 3 (SNX3) inhibitor. SNX3-IN-1 reduces SNX3 protein expression and inhibits SNX3-mediated activation of the Wnt/beta-catenin signaling pathway. SNX3-IN-1 inhibits the proliferation and migration of pulmonary fibrosis-related cells, and decreases the expression of fibrosis markers alpha-SMA and COL-1. SNX3-IN-1 can be used in research related to pulmonary fibrosis[1].
Molekulargewicht:
396.43
CAS Nummer:
[2344793-72-0]
Formel:
C23H24O6
Target-Kategorie:
Wnt,beta-catenin
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten